Premium
NAD + ‐Dependent DNA Ligase: A novel target waiting for the right inhibitor
Author(s) -
Dwivedi Namrata,
Dube Divya,
Pandey Jyoti,
Singh Biswajit,
Kukshal Vandna,
Ramachandran Ravishankar,
Tripathi Rama Pati
Publication year - 2008
Publication title -
medicinal research reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.868
H-Index - 130
eISSN - 1098-1128
pISSN - 0198-6325
DOI - 10.1002/med.20114
Subject(s) - nad+ kinase , dna ligase , dna , chemistry , genetics , microbiology and biotechnology , biology , biochemistry , enzyme
DNA ligases (EC.6.5.1.1) are key enzymes that catalyze the formation of phosphodiester bonds at single stranded or double stranded breaks between adjacent 5′ phosphoryl and 3′ hydroxyl groups of DNA. These enzymes are important for survival because they are involved in major cellular processes like DNA replication/repair and recombination. DNA ligases can be classified into two groups on the basis of their cofactor specificities. NAD + ‐dependent DNA ligases are present in bacteria, some entomopox viruses and mimi virus while ATP‐dependent DNA ligases are ubiquitous. The former have recently been drawing a lot of attention as novel targets for antibiotics to overcome current drug resistance issues. Currently a diverse range of inhibitors have been identified. There are several issues to be addressed in the quest for optimized inhibitors of the enzyme. In the first part of the review we summarize current structural work on these enzymes. Subsequently we describe the currently available classes of inhibitors. We also address modalities to improve the specificity and potencies of new inhibitors identified using protein structure based rational approaches. In conclusion, NAD + ‐dependent ligases show great promise and represent a novel drug target whose time has come. © 2007 Wiley Periodicals, Inc. Med Res Rev, 28, No. 4, 545–568, 2008